Meeting
2020 ASCO Quality Care Symposium
The effects of COVID-19 on new oral oncolytic treatments.
Authors
Rachel L. Mitchell
Tennessee Oncology, Nashville, TN
Rachel L. Mitchell, Edward Arrowsmith, Jack L. Taylor, Stephen Matthew Schleicher, Natalie R. Dickson, Stacey McCullough
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
On-Demand Poster Session: Health Equity and Disparities
Track
Health Care Access, Equity, and Disparities
Sub Track
Access to Treatment and Supportive Care
Citation
J Clin Oncol 38, 2020 (suppl 29; abstr 102)
DOI
10.1200/JCO.2020.38.29_suppl.102
Abstract #
102
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Dipti Shah
Poster
2024 ASCO Quality Care Symposium
Elevating the patient voice: Understanding treatment preferences in patients with advanced prostate cancer.
First Author: Elizabeth R. Kessler
Poster
2024 ASCO Breakthrough
Opioid access barriers for cancer pain relief in Vietnam: A qualitative study.
First Author: Trang Nguyen
Poster
2024 ASCO Annual Meeting
Cost-effectiveness of single-day intravenous fosaprepitant versus three-day oral aprepitant anti-emetic regimen in pediatric patients receiving highly-emetogenic chemotherapy.
First Author: Manraj Singh Sra